Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-11-26

AUTHORS

Shigehiro Karashima, Takashi Yoneda, Mitsuhiro Kometani, Masashi Ohe, Shunsuke Mori, Toshitaka Sawamura, Kenji Furukawa, Takashi Seta, Masakazu Yamagishi, Yoshiyu Takeda

ABSTRACT

The mineralocorticoid receptor (MR) is expressed in the kidneys and in adipose tissue, and primary aldosteronism (PA) is associated with metabolic syndrome. This study assessed the effects of MR blockade by eplerenone (EPL) and spironolactone (SPL) on blood pressure (BP) and metabolic factors in patients with PA. Fifty-four patients with PA were treated with one of two MRAs, EPL (25–100 mg daily, n=27) or SPL (12.5–100 mg daily, n=27) for 12 months. Visceral (VAT) and subcutaneous adipose tissue were quantified using CT and FatScan imaging analysis software. Body mass index, homeostasis model assessment-insulin resistance (HOMA-IR), serum creatinine, potassium and lipids, urinary albumin excretion (UAE) and plasma aldosterone concentration (PAC) and plasma renin activity (PRA) were measured before and after treatment. EPL and SPL decreased BP and increased serum potassium levels to similar degrees. PAC and PRA did not differ between the two groups. Although treatment with the MRAs did not change HOMA-IR or serum lipids, they significantly decreased UAE and VAT (P<0.05). These results suggest that EPL and SPL are effective and safe for the treatment of PA. The long-term metabolic and renal effects of these MRAs should be further investigated. More... »

PAGES

133-137

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/hr.2015.129

DOI

http://dx.doi.org/10.1038/hr.2015.129

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1008996134

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26606875


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Pressure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Eplerenone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hyperaldosteronism", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Function Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mineralocorticoid Receptor Antagonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Potassium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Spironolactone", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.9707.9", 
          "name": [
            "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Karashima", 
        "givenName": "Shigehiro", 
        "id": "sg:person.01014464376.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014464376.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.9707.9", 
          "name": [
            "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yoneda", 
        "givenName": "Takashi", 
        "id": "sg:person.01327041750.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327041750.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.9707.9", 
          "name": [
            "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kometani", 
        "givenName": "Mitsuhiro", 
        "id": "sg:person.01177026176.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177026176.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.9707.9", 
          "name": [
            "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ohe", 
        "givenName": "Masashi", 
        "id": "sg:person.01161622470.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01161622470.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.9707.9", 
          "name": [
            "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mori", 
        "givenName": "Shunsuke", 
        "id": "sg:person.0634436105.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634436105.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.9707.9", 
          "name": [
            "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sawamura", 
        "givenName": "Toshitaka", 
        "id": "sg:person.01245141376.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245141376.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Kanazawa Insurance Hospital, Kanazawa, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Internal Medicine, Kanazawa Insurance Hospital, Kanazawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Furukawa", 
        "givenName": "Kenji", 
        "id": "sg:person.01005476637.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005476637.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Saiseikai Kanazawa Hospital, Kanazawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.416609.c", 
          "name": [
            "Department of Internal Medicine, Saiseikai Kanazawa Hospital, Kanazawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Seta", 
        "givenName": "Takashi", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Disease, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.9707.9", 
          "name": [
            "Department of Cardiovascular Disease, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yamagishi", 
        "givenName": "Masakazu", 
        "id": "sg:person.01111610241.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01111610241.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.9707.9", 
          "name": [
            "Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takeda", 
        "givenName": "Yoshiyu", 
        "id": "sg:person.011107121707.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011107121707.93"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/hr.2011.35", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020745088", 
          "https://doi.org/10.1038/hr.2011.35"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/hr.2012.182", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007825260", 
          "https://doi.org/10.1038/hr.2012.182"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/hr.2013.30", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042802941", 
          "https://doi.org/10.1038/hr.2013.30"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03347840", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039211825", 
          "https://doi.org/10.1007/bf03347840"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/hr.2010.221", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020353836", 
          "https://doi.org/10.1038/hr.2010.221"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/hr.2010.166", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033022843", 
          "https://doi.org/10.1038/hr.2010.166"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-11-26", 
    "datePublishedReg": "2015-11-26", 
    "description": "The mineralocorticoid receptor (MR) is expressed in the kidneys and in adipose tissue, and primary aldosteronism (PA) is associated with metabolic syndrome. This study assessed the effects of MR blockade by eplerenone (EPL) and spironolactone (SPL) on blood pressure (BP) and metabolic factors in patients with PA. Fifty-four patients with PA were treated with one of two MRAs, EPL (25\u2013100 mg daily, n=27) or SPL (12.5\u2013100 mg daily, n=27) for 12 months. Visceral (VAT) and subcutaneous adipose tissue were quantified using CT and FatScan imaging analysis software. Body mass index, homeostasis model assessment-insulin resistance (HOMA-IR), serum creatinine, potassium and lipids, urinary albumin excretion (UAE) and plasma aldosterone concentration (PAC) and plasma renin activity (PRA) were measured before and after treatment. EPL and SPL decreased BP and increased serum potassium levels to similar degrees. PAC and PRA did not differ between the two groups. Although treatment with the MRAs did not change HOMA-IR or serum lipids, they significantly decreased UAE and VAT (P<0.05). These results suggest that EPL and SPL are effective and safe for the treatment of PA. The long-term metabolic and renal effects of these MRAs should be further investigated.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/hr.2015.129", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1313717", 
        "issn": [
          "0916-9636", 
          "1348-4214"
        ], 
        "name": "Hypertension Research", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "39"
      }
    ], 
    "keywords": [
      "homeostasis model assessment-insulin resistance", 
      "urinary albumin excretion", 
      "plasma renin activity", 
      "primary aldosteronism", 
      "blood pressure", 
      "mineralocorticoid receptor", 
      "adipose tissue", 
      "model assessment-insulin resistance", 
      "treatment of PA", 
      "assessment-insulin resistance", 
      "serum potassium levels", 
      "body mass index", 
      "subcutaneous adipose tissue", 
      "MR blockade", 
      "albumin excretion", 
      "renin activity", 
      "renal effects", 
      "serum creatinine", 
      "aldosterone concentration", 
      "serum lipids", 
      "metabolic syndrome", 
      "mass index", 
      "metabolic factors", 
      "eplerenone", 
      "spironolactone", 
      "potassium levels", 
      "aldosteronism", 
      "patients", 
      "similar degree", 
      "treatment", 
      "MRA", 
      "tissue", 
      "creatinine", 
      "lipids", 
      "syndrome", 
      "blockade", 
      "Visceral", 
      "kidney", 
      "excretion", 
      "months", 
      "CT", 
      "receptors", 
      "effect", 
      "group", 
      "index", 
      "factors", 
      "levels", 
      "activity", 
      "VAT", 
      "study", 
      "analysis software", 
      "potassium", 
      "resistance", 
      "pressure", 
      "concentration", 
      "degree", 
      "PAC", 
      "comparison", 
      "results", 
      "software"
    ], 
    "name": "Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism", 
    "pagination": "133-137", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1008996134"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/hr.2015.129"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26606875"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/hr.2015.129", 
      "https://app.dimensions.ai/details/publication/pub.1008996134"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:41", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_684.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/hr.2015.129"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/hr.2015.129'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/hr.2015.129'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/hr.2015.129'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/hr.2015.129'


 

This table displays all metadata directly associated to this object as RDF triples.

267 TRIPLES      21 PREDICATES      104 URIs      90 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/hr.2015.129 schema:about N121e243f3b354ac48c6be904267a88e3
2 N15f3292652c74ed0902110dbc478e714
3 N27cd313236e640e29a05f3c45f91f105
4 N2c6322d8dcd74f1fb8b8f10eeb9476c1
5 N360e77efc29f4f61b7d20b281e94a5e3
6 N6ce801e475384c13b537528d32652eb4
7 N7a57051e018440e9ae49bb44adfe6a5e
8 N84c4121a25c5474fa77038c18f09cca5
9 N9ef41bea2c4e438799e15d72207d00fc
10 Nb165a8dd8d864839b299b56766535da4
11 Ncaffe590d38f4e3eab187908c91a5941
12 Nd4f3a6d9dd3b4fc49169435f27c9127c
13 Nff28133025204887a144efacd789d392
14 anzsrc-for:11
15 anzsrc-for:1103
16 schema:author N36295dec7f1c4ab7945f6031e815bd24
17 schema:citation sg:pub.10.1007/bf03347840
18 sg:pub.10.1038/hr.2010.166
19 sg:pub.10.1038/hr.2010.221
20 sg:pub.10.1038/hr.2011.35
21 sg:pub.10.1038/hr.2012.182
22 sg:pub.10.1038/hr.2013.30
23 schema:datePublished 2015-11-26
24 schema:datePublishedReg 2015-11-26
25 schema:description The mineralocorticoid receptor (MR) is expressed in the kidneys and in adipose tissue, and primary aldosteronism (PA) is associated with metabolic syndrome. This study assessed the effects of MR blockade by eplerenone (EPL) and spironolactone (SPL) on blood pressure (BP) and metabolic factors in patients with PA. Fifty-four patients with PA were treated with one of two MRAs, EPL (25–100 mg daily, n=27) or SPL (12.5–100 mg daily, n=27) for 12 months. Visceral (VAT) and subcutaneous adipose tissue were quantified using CT and FatScan imaging analysis software. Body mass index, homeostasis model assessment-insulin resistance (HOMA-IR), serum creatinine, potassium and lipids, urinary albumin excretion (UAE) and plasma aldosterone concentration (PAC) and plasma renin activity (PRA) were measured before and after treatment. EPL and SPL decreased BP and increased serum potassium levels to similar degrees. PAC and PRA did not differ between the two groups. Although treatment with the MRAs did not change HOMA-IR or serum lipids, they significantly decreased UAE and VAT (P<0.05). These results suggest that EPL and SPL are effective and safe for the treatment of PA. The long-term metabolic and renal effects of these MRAs should be further investigated.
26 schema:genre article
27 schema:isAccessibleForFree true
28 schema:isPartOf N9b79d02baecc433cbb13216ab08b5f1f
29 Nb7d54d8e20d9416bb73afb2323d66552
30 sg:journal.1313717
31 schema:keywords CT
32 MR blockade
33 MRA
34 PAC
35 VAT
36 Visceral
37 activity
38 adipose tissue
39 albumin excretion
40 aldosterone concentration
41 aldosteronism
42 analysis software
43 assessment-insulin resistance
44 blockade
45 blood pressure
46 body mass index
47 comparison
48 concentration
49 creatinine
50 degree
51 effect
52 eplerenone
53 excretion
54 factors
55 group
56 homeostasis model assessment-insulin resistance
57 index
58 kidney
59 levels
60 lipids
61 mass index
62 metabolic factors
63 metabolic syndrome
64 mineralocorticoid receptor
65 model assessment-insulin resistance
66 months
67 patients
68 plasma renin activity
69 potassium
70 potassium levels
71 pressure
72 primary aldosteronism
73 receptors
74 renal effects
75 renin activity
76 resistance
77 results
78 serum creatinine
79 serum lipids
80 serum potassium levels
81 similar degree
82 software
83 spironolactone
84 study
85 subcutaneous adipose tissue
86 syndrome
87 tissue
88 treatment
89 treatment of PA
90 urinary albumin excretion
91 schema:name Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism
92 schema:pagination 133-137
93 schema:productId N1486de17e08b41009a1e91cd93635130
94 Nb2ce5af6c10d4b569cc83a874588bc5c
95 Nd371fde5d2154de4aa7f4e7b0f36e017
96 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008996134
97 https://doi.org/10.1038/hr.2015.129
98 schema:sdDatePublished 2022-10-01T06:41
99 schema:sdLicense https://scigraph.springernature.com/explorer/license/
100 schema:sdPublisher Na46e0f18b160442785c50adf2b64e9c3
101 schema:url https://doi.org/10.1038/hr.2015.129
102 sgo:license sg:explorer/license/
103 sgo:sdDataset articles
104 rdf:type schema:ScholarlyArticle
105 N121e243f3b354ac48c6be904267a88e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Kidney Function Tests
107 rdf:type schema:DefinedTerm
108 N1486de17e08b41009a1e91cd93635130 schema:name doi
109 schema:value 10.1038/hr.2015.129
110 rdf:type schema:PropertyValue
111 N15f3292652c74ed0902110dbc478e714 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Eplerenone
113 rdf:type schema:DefinedTerm
114 N164c86f6ee1e4cfb8b632dc834e56ae2 schema:affiliation grid-institutes:grid.416609.c
115 schema:familyName Seta
116 schema:givenName Takashi
117 rdf:type schema:Person
118 N27cd313236e640e29a05f3c45f91f105 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Aged
120 rdf:type schema:DefinedTerm
121 N2c6322d8dcd74f1fb8b8f10eeb9476c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Adult
123 rdf:type schema:DefinedTerm
124 N3595d5150f8e4e13b57b0581c4b60e78 rdf:first sg:person.01245141376.12
125 rdf:rest N3722f037a562418abe0c2002768d94b0
126 N360e77efc29f4f61b7d20b281e94a5e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Female
128 rdf:type schema:DefinedTerm
129 N36295dec7f1c4ab7945f6031e815bd24 rdf:first sg:person.01014464376.79
130 rdf:rest N9eac0b924f0647789e330b4970dfe34a
131 N3722f037a562418abe0c2002768d94b0 rdf:first sg:person.01005476637.29
132 rdf:rest Nd87a9b5f0fb84bbda0c441fcb5898e41
133 N38adcc8f74b94413aa0da1c54fcd43a0 rdf:first sg:person.011107121707.93
134 rdf:rest rdf:nil
135 N4257394474d0455fa1417dd75c876415 rdf:first sg:person.0634436105.20
136 rdf:rest N3595d5150f8e4e13b57b0581c4b60e78
137 N6ce801e475384c13b537528d32652eb4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Middle Aged
139 rdf:type schema:DefinedTerm
140 N7a57051e018440e9ae49bb44adfe6a5e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Male
142 rdf:type schema:DefinedTerm
143 N84c4121a25c5474fa77038c18f09cca5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Potassium
145 rdf:type schema:DefinedTerm
146 N9b79d02baecc433cbb13216ab08b5f1f schema:volumeNumber 39
147 rdf:type schema:PublicationVolume
148 N9eac0b924f0647789e330b4970dfe34a rdf:first sg:person.01327041750.74
149 rdf:rest Ncc5d4c29eab744bb9b73f9cec8e05d38
150 N9ef41bea2c4e438799e15d72207d00fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Spironolactone
152 rdf:type schema:DefinedTerm
153 Na46e0f18b160442785c50adf2b64e9c3 schema:name Springer Nature - SN SciGraph project
154 rdf:type schema:Organization
155 Nb165a8dd8d864839b299b56766535da4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Hyperaldosteronism
157 rdf:type schema:DefinedTerm
158 Nb2ce5af6c10d4b569cc83a874588bc5c schema:name dimensions_id
159 schema:value pub.1008996134
160 rdf:type schema:PropertyValue
161 Nb7d54d8e20d9416bb73afb2323d66552 schema:issueNumber 3
162 rdf:type schema:PublicationIssue
163 Nba793874a1334c1fabc7058fef917111 rdf:first sg:person.01161622470.54
164 rdf:rest N4257394474d0455fa1417dd75c876415
165 Nc64746fdb53f4d678cc558cab136ec5d rdf:first sg:person.01111610241.58
166 rdf:rest N38adcc8f74b94413aa0da1c54fcd43a0
167 Ncaffe590d38f4e3eab187908c91a5941 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Mineralocorticoid Receptor Antagonists
169 rdf:type schema:DefinedTerm
170 Ncc5d4c29eab744bb9b73f9cec8e05d38 rdf:first sg:person.01177026176.61
171 rdf:rest Nba793874a1334c1fabc7058fef917111
172 Nd371fde5d2154de4aa7f4e7b0f36e017 schema:name pubmed_id
173 schema:value 26606875
174 rdf:type schema:PropertyValue
175 Nd4f3a6d9dd3b4fc49169435f27c9127c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Humans
177 rdf:type schema:DefinedTerm
178 Nd87a9b5f0fb84bbda0c441fcb5898e41 rdf:first N164c86f6ee1e4cfb8b632dc834e56ae2
179 rdf:rest Nc64746fdb53f4d678cc558cab136ec5d
180 Nff28133025204887a144efacd789d392 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Blood Pressure
182 rdf:type schema:DefinedTerm
183 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
184 schema:name Medical and Health Sciences
185 rdf:type schema:DefinedTerm
186 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
187 schema:name Clinical Sciences
188 rdf:type schema:DefinedTerm
189 sg:journal.1313717 schema:issn 0916-9636
190 1348-4214
191 schema:name Hypertension Research
192 schema:publisher Springer Nature
193 rdf:type schema:Periodical
194 sg:person.01005476637.29 schema:affiliation grid-institutes:None
195 schema:familyName Furukawa
196 schema:givenName Kenji
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005476637.29
198 rdf:type schema:Person
199 sg:person.01014464376.79 schema:affiliation grid-institutes:grid.9707.9
200 schema:familyName Karashima
201 schema:givenName Shigehiro
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014464376.79
203 rdf:type schema:Person
204 sg:person.011107121707.93 schema:affiliation grid-institutes:grid.9707.9
205 schema:familyName Takeda
206 schema:givenName Yoshiyu
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011107121707.93
208 rdf:type schema:Person
209 sg:person.01111610241.58 schema:affiliation grid-institutes:grid.9707.9
210 schema:familyName Yamagishi
211 schema:givenName Masakazu
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01111610241.58
213 rdf:type schema:Person
214 sg:person.01161622470.54 schema:affiliation grid-institutes:grid.9707.9
215 schema:familyName Ohe
216 schema:givenName Masashi
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01161622470.54
218 rdf:type schema:Person
219 sg:person.01177026176.61 schema:affiliation grid-institutes:grid.9707.9
220 schema:familyName Kometani
221 schema:givenName Mitsuhiro
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177026176.61
223 rdf:type schema:Person
224 sg:person.01245141376.12 schema:affiliation grid-institutes:grid.9707.9
225 schema:familyName Sawamura
226 schema:givenName Toshitaka
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245141376.12
228 rdf:type schema:Person
229 sg:person.01327041750.74 schema:affiliation grid-institutes:grid.9707.9
230 schema:familyName Yoneda
231 schema:givenName Takashi
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327041750.74
233 rdf:type schema:Person
234 sg:person.0634436105.20 schema:affiliation grid-institutes:grid.9707.9
235 schema:familyName Mori
236 schema:givenName Shunsuke
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634436105.20
238 rdf:type schema:Person
239 sg:pub.10.1007/bf03347840 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039211825
240 https://doi.org/10.1007/bf03347840
241 rdf:type schema:CreativeWork
242 sg:pub.10.1038/hr.2010.166 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033022843
243 https://doi.org/10.1038/hr.2010.166
244 rdf:type schema:CreativeWork
245 sg:pub.10.1038/hr.2010.221 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020353836
246 https://doi.org/10.1038/hr.2010.221
247 rdf:type schema:CreativeWork
248 sg:pub.10.1038/hr.2011.35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020745088
249 https://doi.org/10.1038/hr.2011.35
250 rdf:type schema:CreativeWork
251 sg:pub.10.1038/hr.2012.182 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007825260
252 https://doi.org/10.1038/hr.2012.182
253 rdf:type schema:CreativeWork
254 sg:pub.10.1038/hr.2013.30 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042802941
255 https://doi.org/10.1038/hr.2013.30
256 rdf:type schema:CreativeWork
257 grid-institutes:None schema:alternateName Department of Internal Medicine, Kanazawa Insurance Hospital, Kanazawa, Japan
258 schema:name Department of Internal Medicine, Kanazawa Insurance Hospital, Kanazawa, Japan
259 rdf:type schema:Organization
260 grid-institutes:grid.416609.c schema:alternateName Department of Internal Medicine, Saiseikai Kanazawa Hospital, Kanazawa, Japan
261 schema:name Department of Internal Medicine, Saiseikai Kanazawa Hospital, Kanazawa, Japan
262 rdf:type schema:Organization
263 grid-institutes:grid.9707.9 schema:alternateName Department of Cardiovascular Disease, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan
264 Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan
265 schema:name Department of Cardiovascular Disease, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan
266 Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan
267 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...